IL154485A0 - Lipo-or amphiphilic scintillators and their use in assays - Google Patents

Lipo-or amphiphilic scintillators and their use in assays

Info

Publication number
IL154485A0
IL154485A0 IL15448501A IL15448501A IL154485A0 IL 154485 A0 IL154485 A0 IL 154485A0 IL 15448501 A IL15448501 A IL 15448501A IL 15448501 A IL15448501 A IL 15448501A IL 154485 A0 IL154485 A0 IL 154485A0
Authority
IL
Israel
Prior art keywords
scintillators
lipo
amphiphilic
assays
amphiphilic scintillators
Prior art date
Application number
IL15448501A
Original Assignee
Sense Proteomic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0020503A external-priority patent/GB0020503D0/en
Application filed by Sense Proteomic Ltd filed Critical Sense Proteomic Ltd
Publication of IL154485A0 publication Critical patent/IL154485A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Materials Engineering (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL15448501A 2000-08-18 2001-08-17 Lipo-or amphiphilic scintillators and their use in assays IL154485A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0020503A GB0020503D0 (en) 2000-08-18 2000-08-18 Compounds
US24799400P 2000-11-14 2000-11-14
PCT/GB2001/003695 WO2002014290A1 (en) 2000-08-18 2001-08-17 Lipo- or amphiphilic scintillators and their use in assays

Publications (1)

Publication Number Publication Date
IL154485A0 true IL154485A0 (en) 2003-09-17

Family

ID=26244864

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15448501A IL154485A0 (en) 2000-08-18 2001-08-17 Lipo-or amphiphilic scintillators and their use in assays

Country Status (10)

Country Link
EP (1) EP1315707A1 (en)
JP (1) JP2004506754A (en)
KR (1) KR20030066601A (en)
CN (1) CN1458925A (en)
AU (1) AU2001278633A1 (en)
BR (1) BR0113328A (en)
CA (1) CA2420006A1 (en)
GB (1) GB2383329A (en)
IL (1) IL154485A0 (en)
WO (1) WO2002014290A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7553559B2 (en) * 2005-12-21 2009-06-30 Lg Display Co., Ltd. Hexatriene derivatives for use as blue emitting materials for organic electroluminescent devices
EP1892530A1 (en) * 2006-08-25 2008-02-27 Boehringer Ingelheim Pharma GmbH & Co. KG Method for determining transport activity of a transport protein
CN104327005B (en) * 2014-10-21 2016-08-24 华烁科技股份有限公司 The preparation method of 2,5-diphenyloxazole
JP2022512762A (en) * 2018-10-21 2022-02-07 ザ ユニバーシティ オブ カンザス Methods for Producing Therapeutic Delivery Platforms
KR102288775B1 (en) * 2019-03-26 2021-08-12 동국대학교 산학협력단 Scintillator composition and Scintillator using the same
WO2020197032A1 (en) * 2019-03-26 2020-10-01 동국대학교 산학협력단 Scintillator composition and scintilator using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63227576A (en) * 1987-03-13 1988-09-21 Hamamatsu Photonics Kk Biphenyloxazole derivative, production and use thereof
GB2342350A (en) * 1998-10-05 2000-04-12 Univ Nottingham Trent Solid supports containing oxazole scintillants

Also Published As

Publication number Publication date
BR0113328A (en) 2003-07-29
JP2004506754A (en) 2004-03-04
EP1315707A1 (en) 2003-06-04
CA2420006A1 (en) 2002-02-21
AU2001278633A1 (en) 2002-02-25
KR20030066601A (en) 2003-08-09
WO2002014290A1 (en) 2002-02-21
GB0306216D0 (en) 2003-04-23
CN1458925A (en) 2003-11-26
GB2383329A (en) 2003-06-25

Similar Documents

Publication Publication Date Title
HUP0301417A2 (en) Antimikrobal and contraceptive composition and their use
MXPA03005923A (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines.
ID26427A (en) BENDET SHEETS USED IN USE ONCE
GB0009521D0 (en) Improvements to modular buildings and material used in their construction
IL156161A0 (en) Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors
GB0101035D0 (en) Formulation and use thereof
IL163942A0 (en) Improvements in and relating to pelvic floor excercisers and indicators
EP1281353A4 (en) Pulsometer and measuring system comprising the same
GB0306216D0 (en) Lipo-or amphiphilic scintillators and their use in assays
GB0026134D0 (en) Peptides and their use
AU2003218261A8 (en) Improvements in pharmaceutical discovery and development
GB0007530D0 (en) Trityl-type compounds and their use
GB0021497D0 (en) Compounds and their use
GB0028879D0 (en) Adsorbents and their use
GB0026229D0 (en) Liquid soap and airfreshener in one
AU8975701A (en) Novel composition and use
HK1067664A1 (en) The use of ribozymes in the detection of adventitious agents
AU2002220626A1 (en) 3-nitroisoxazoles and their use in the protection of materials
GB0013185D0 (en) Films and uses thereof
GB0212499D0 (en) Transport building and use thereof
AU5104101A (en) Composition and use
AU2001291750A1 (en) Lat peptides and their use in assays for identifying immunosuppressants
GB9929581D0 (en) Comjpositions and their use
GB0018789D0 (en) Improvements in and relating to building constructions and building elements for use therein
GB0324205D0 (en) Piperidinyl-diarylsilanol compounds and their use in threrapy